TransCode Therapeutics - SEC Filing

Por um escritor misterioso

Descrição

TransCode Therapeutics Manhattan Street Capital

EDGAR Filing Documents for 0001104659-21-029169

TransCode Therapeutics - SEC Filing

TransCode Therapeutics Inc (RNAZ) Stock Message Board

ALNYLAM PHARMACEUTICALS, INC. - 10K - Annual Report - February 23

EDGAR Filing Documents for 0001104659-21-029169

Capital Ventures International Increases Ownership in Marathon

TransCode Therapeutics Manhattan Street Capital

TransCode Therapeutics, Inc. Announces Pricing of Initial Public

de por adulto (o preço varia de acordo com o tamanho do grupo)

Sugerir pesquisas